Patient case studies

Meet patients with different hypoglycemia complications

Professor Kamlesh Khunti, Dr Yingying Luo, and Professor Ulrik Pedersen-Bjergaard invite you to participate in three case studies that focus on the therapeutic management of patients with hypoglycemia complications.

The case studies are no longer open for accreditation but will continue to be available for participation.

Each study will take up to 15 minutes to complete. Please take a moment to fill in the evaluation form to help us deliver the most relevant educational programs for your learning.

Yingying Luo

Yingying Luo is an associate clinical professor at Peking University People’s Hospital, Peking, China. She obtained her medical doctor degree from Peking University in 2008. Her major research focus is the intervention study and genetic study of type 2 diabetes. She has participated in several national clinical studies including “Beijing Pre-diabetes Reversion Program” and “China National Diabetes and Metabolic Disorders Study” and has published several peer reviewed journal articles.

Currently, Dr Luo is the youngest committee member of Endocrinology and Metabolism Branch of Chinese Medical Association. She is also a member and secretary of the Endocrinology Society of Beijing Medical Association and is the only Chinese member of International Hypoglycemia Study Group (IHSG). From 2015 to 2017, Dr Luo was the editorial board member of Chinese Journal of Diabetes (issue for primary care physicians).

Disclosures

Received grants/research support or honoraria/consultation fees from Lilly.

Kamlesh Khunti

Kamlesh Khunti is Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester, UK. He is Co-Director of the Leicester Diabetes Centre and leads a research group that is currently working on the early identification of, and interventions with, people who have diabetes or are at increased risk of developing diabetes. His work has influenced national and international guidelines on the screening and management of people with diabetes. Professor Khunti is also Director of the UK National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care East Midlands and Director of The Real World Evidence Unit. He is a NIHR Senior Investigator and Principal Investigator on several major national and international studies. He has published over 650 articles. 

Professor Khunti is a Fellow of the Academy of Medical Sciences and is currently an advisor to the Department of Health, a Clinical Advisor for the National Institute for Health and Care Excellence (NICE) and Secretary of the Primary Care Study Group of the European Association for the Study of Diabetes. He is Past Chair of the Department of Health–RCGP Committee on Classification of Diabetes and is Past Chair of the NICE Guidelines on Prevention of Diabetes. In addition, he is Co-Director of the Diabetes MSc at Leicester University. He has won numerous awards nationally and internationally.

Disclosures

Grants/Research Support: AstraZeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Pfizer, Boehringer Ingelheim and Merck Sharp & Dohme.

Ulrik Pedersen-Bjergaard

Ulrik Pedersen-Bjergaard is a Chief Physician at Nordsjællands Univeristy Hospital – Hillerød, Denmark, and Professor at the University of Copenhagen. He received his medical degree from the University of Copenhagen in 1986. Following clinical training in general internal medicine and endocrinology in several Danish University hospitals and the Steno Diabetes Center, he completed his thesis “Severe hypoglycaemia in type 1 diabetes: impact of the renin-angiotensin system and other risk factors” at Nordsjællands University Hospital – Hillerød. Dr Pedersen-Bjergaard has published extensively, mainly in the field of type I diabetes and complications related to insulin treatment, with a special interest in hypoglycemia. He is a member of The International Hypoglycaemia Study Group.

Disclosures

Advisory Panel/Speaker honorarium: AstraZeneca, Novo Nordisk, Sanofi, UNEEG, Zealand Pharma.

Hypoglycemia and impaired renal function in type 2 diabetes

Upon successful completion of this case study, learners will be able to:

  1. Describe the mechanisms which increase the risk of hypoglycemia in patients with renal disease and diabetes.
  2. Explain the therapeutic considerations required for patients with diabetes and renal disease.

Hypoglycemia and cardiovascular disease in type 2 diabetes

Upon successful completion of this case study, learners will be able to:

  1. Explain the different cardiovascular risks that have been linked to hypoglycemia in people with diabetes.
  2. Evaluate how these cardiovascular risks can be efficiently identified and managed.

Hypoglycemia and cognitive function

Upon successful completion of this case study, learners will be able to:

  1. Discuss the relationship between hypoglycemia and cognitive function using the latest evidence.
  2. Evaluate how to manage the risk and consequences of the cognitive effects of hypoglycemia.

To view transcripts in other languages:

  1. Select your preferred language in the MENU tab.
  2. Click on the TRANSCRIPT tab to view the translated text alongside the case study content.

Hypoglycemia and cardiovascular disease in type 2 diabetes

Hypoglycemia and cognitive function

Hypoglycemia and impaired renal function in type 2 diabetes

Please create a free account or login to access this content

Scroll to Top

Please create a free account or login to access this content

Register

  • This field is for validation purposes and should be left unchanged.
* Required

Login

Contact us

  • This field is for validation purposes and should be left unchanged.

Sign up

* indicates required